Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer
Authors:
Open Access
- 16 June 2009
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 101 (2) , 335-341
Abstract
Background: Methods: Results: Conclusion:Keywords
This publication has 29 references indexed in Scilit:
- Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker for Nasopharyngeal CarcinomaClinical Cancer Research, 2004
- Widespread Expression of Serum Amyloid A in Histologically Normal Human Tissues: Predominant Localization to the EpitheliumJournal of Histochemistry & Cytochemistry, 1998
- CA 125 may not reflect disease status in patients with uterine serous carcinomaCancer, 1998
- Early Pathologic Stage Clear Cell Carcinoma and Uterine Papillary Serous Carcinoma of the EndometriumInternational Journal of Gynecological Pathology, 1995
- Uterine Papillary Serous Carcinoma: Patterns of Metastatic SpreadGynecologic Oncology, 1994
- Evolution of the Serum Amyloid A (SAA) Protein SuperfamilyGenomics, 1994
- Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1990
- Virulence of papillary endometrial carcinomaGynecologic Oncology, 1990
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983
- SERUM AMYLOID P-COMPONENT LEVELS IN AMYLOIDOSIS, CONNECTIVE-TISSUE DISEASES, INFECTION, AND MALIGNANCY AS COMPARED TO NORMAL SERUM1979